Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Chien Ho Lin |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder / Chien Ho Lin en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 5 (Octubre)
[artículo]
Título : Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder : A randomized, double blind, controlled study Tipo de documento: texto impreso Autores: Chien Ho Lin, Autor ; Shih Hsien Lin, Autor ; Fong Lin Jang, Autor Fecha de publicación: 2022 Artículo en la página: pp. 563-568 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Aripiprazol, Trastorno depresivo mayor, No refractario Resumen: Second-generation (atypical) antipsychotics have been accepted as an adjunctive medication in patients with treatment-resistant depression. This clinical trial evaluated the efficacy and safety of low-dose aripiprazole combined with regular-dose sertraline for acute major depressive episode in non-treatment-resistant depression outpatients. Link: ./index.php?lvl=notice_display&id=29349
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 563-568[artículo] Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder : A randomized, double blind, controlled study [texto impreso] / Chien Ho Lin, Autor ; Shih Hsien Lin, Autor ; Fong Lin Jang, Autor . - 2022 . - pp. 563-568.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 563-568
Palabras clave: Aripiprazol, Trastorno depresivo mayor, No refractario Resumen: Second-generation (atypical) antipsychotics have been accepted as an adjunctive medication in patients with treatment-resistant depression. This clinical trial evaluated the efficacy and safety of low-dose aripiprazole combined with regular-dose sertraline for acute major depressive episode in non-treatment-resistant depression outpatients. Link: ./index.php?lvl=notice_display&id=29349